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Abstract: Caves are stable environments that favour the development of several microorganisms. 
The aspergilli represent a large number of species isolated from caves including strains 
capable of causing serious invasive opportunistic infections in humans. Considering that 
caves may harbour resistant strains to many antibiotics, investigation on the response of 
opportunistic aspergilli, isolated from pristine and tourist caves to antifungal agents and the 
mechanisms involved in resistance might be clinically relevant. A total of 32 strains of the 
species Aspergillus candidus, A. flavus, A. fumigatus, A. niger, A. tamarii, and A. terreus 
were isolated from caves in the iron quadrangle in Brazil. The strains were tested for their 
susceptibility to amphotericin B (AMB), itraconazole, voriconazole and terbinafine. One strain 
was analysed for the mechanism involved in the AMB-resistance, i.e., ergosterol content, 
lipid peroxidation and enzymatic activity of the antioxidant system. Terbinafine minimum 
inhibitory concentrations (MICs) ranged between 0.003 and 1.0 µg/mL; voriconazole MICs 
ranged between 2.0 and >16.0 µg/mL; itraconazole MICs ranged between 0.25 and 8.0 
µg/mL and amphotericin B MICs ranged between 0.03 and 4.0 µg/mL. The AMB-resistant 
strain of A. flavus was detected with MIC value of 4 µg/mL. Resistance to AMB relied on 
higher ergosterol levels and increased enzymatic activity of the peroxidase and superoxide-
dismutase, with lower lipid peroxidation. These results enhance the knowledge of natural 
antifungal resistance in the subterranean ecosystem, and broaden the knowledge about the 
subterranean microbiota.
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INTRODUCTION
Caves are unique ecosystems with environmental 
characteristics that may favour the growth of several 
microorganisms (Poulson & White, 1969; Culver 
& White, 2005). The genus Aspergillus has often 
been reported in subterranean environments and 
represents many of the identified fungal species 
isolated from caves (Vanderwolf et al., 2013), 
including several species capable of causing serious 
invasive opportunistic infections in humans (Taylor et 
al., 2013; Vanderwolf et al., 2013; Taylor et al., 2014). 
The species Aspergillus fumigatus (Perfect et al., 2001), 
A. flavus (Walsh et al., 2008), A. terreus (Iwen et al., 
1998; Mokaddas et al., 2010), and A. niger (Person et 
al., 2010) are the main causative agents of invasive 
pulmonary aspergillosis (IPA) in humans (Walsh et 
al., 2008; Kousha et al., 2011). Although IPA occurs 
mainly among immunocompromised individuals, 
cases of pulmonary infection by aspergilli have been 
reported in immunocompetent individuals (Person 
et al., 2010; Kousha et al., 2011). The polyenes and 
azoles are the agents most commonly used in the 
treatment of IPA. Resistance to these drugs have 
been increasingly reported (Ghannoum & Rice, 
1999; Singh, 2001; Kousha et al., 2011) raising the 
possibility of natural acquired resistance (Loeffler & 
Stevens, 2003).
Most caves are considered extreme environments 
due to their oligotrophic conditions. Normally, cave-
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dwelling organisms adapt to this nutrient limitation 
in order to survive and colonize the ecosystem (Culver 
& White, 2005). Among cave microorganisms, this 
adaptation may occur at the morphological and/or 
physiological level. Competition for substrate among 
sympatric fungal species normally leads to production 
of metabolites capable of eliminating competition, 
such as antibiotics, acidifying metabolites, and toxins 
(Griffin, 1994). Antibiotic resistance among cave 
isolated bacteria has been described as result of genetic 
background and selective forces involved in various 
ecological interactions in the subterranean environment 
(Bhullar et al., 2012). Fungi may also be undergoing 
the same process, which may cause natural selection 
of opportunistic and pathogenic strains resistant to 
currently used antifungal drugs. The fact that several 
caves have large mats of actinomycetes competing with 
fungi for substrates and that the most potent antifungal 
drug (amphotericin B) used in treatment of IPA was 
firstly obtained from actinomycetes (Streptomyces 
nodosus) (Svahn et al., 2015), reinforces this hypothesis. 
Thus, prospective studies on the effect of antifungal 
drugs against strains colonizing caves are relevant.
Considering that IPA may represent a silent emerging 
risk to cave visitors, and that caves may harbour 
strains resistant to antifungals, we conducted a 
pioneer investigation on the response of opportunistic 
Aspergillus spp., isolated from pristine and tourist 
caves, to the most commonly used antifungal agents 
(amphotericin B, itraconazole, voriconazole and 
terbinafine) and the mechanisms involved in the 
resistance to AMB.
MATERIALS AND METHODS
Study site
The strains used in this study were obtained from 
eight different caves located in the Iron Quadrangle 
(Quadrilátero Ferrífero, Minas Gerais state, Brazil). 
This region is economically important due to their 
proximity with the state capital, urban/rural areas 
and sites with large mining activities (mainly metal 
ores). Furthermore, cave visitation has increased in 
past years. The strains used in this study were isolated 
from seven iron ore caves: Rola Moça II (Brumadinho, 
Minas Gerais, Brazil- 20°03’38.5” S / 44°00’30.4” W), 
Rola Moça III (Belo Horizonte, Minas Gerais, Brazil- 
20°02’38.1” S / 44°00’23.2” W), Macumba (Sabará, 
Minas Gerais, Brazil- 19°40’01.1” S / 43°40’30.1” W), 
Romeiros (Sabará, Minas Gerais, Brazil- 19°49’00.3” S / 
43°40’35.9” W), Bloco Abatido (Sabará, Minas Gerais, 
Brazil- 19°49’02” S / 43°40’50” W), Cascalhinho (Caeté, 
Minas Gerais, Brazil- 19°48’59.1” S / 43°40’28.7” W), 
Eremita (Sabará, Minas Gerais, Brazil- 19°49’19.5” 
S / 43°40’49.5” W) and one dolomitic cave, Nossa 
Senhora da Conceição da Lapa (Ouro Preto, Minas 
Gerais, Brazil- 20°18’18.4” S / 43°28’20.6” W) (Fig. 1).
Aspergillus strains 
Five species of aspergilli were selected due to their 
association as causative agents of IPA in humans. A 
total of 33 strains of the species Aspergillus candidus 
(Taylor et al., 2014), A. flavus (Ghannoum & Rice, 
1999), A. fumigatus (Perfect et al., 2001), A. niger 
(Perfect et al., 2001), A. terreus (Culver & White, 
2005), and A. tamarii (Culver & White, 2005) were 
used that had previously been isolated from the 
caves during a mycological inventory performed in 
the period between the years 2010/2013. Strains 
were sampled from air by the settle plate technique 
with a 20-minute exposure on Dichloram Rose 
Bengal Cloramphenicol Agar (DRBC, Acumedia 
Laboratories, Lansing, MI USA) and Sabouraud 
Dextrose Agar (SDA, Difco Laboratories, Detroit, MI 
USA) with cloramphenicol (0.1%), and from sediment 
by a 10-fold serial dilution on DRBC (Acumedia). 
These strains are currently deposited in the 
mycological collection of cave fungi in the Mycological 
Laboratory of the Federal University of Minas Gerais 
(Laboratório de Micologia da Universidade Federal 
de Minas Gerais-LM/UFMG, Belo Horizonte, Minas 
Gerais, Brazil).
Identification of species was confirmed through 
analysis of macro and micromorphological 
characteristics in solid media, following standard 
taxonomic keys and recently published works 
(Klich, 2002; Domsch et al., 2007). Two media were 
used for each strain and at different temperature 
regimens: Czapeck Yeast Extract Agar (CYA, Labsynth, 
Diadema, SP Brazil) at 25°C/7d; CYA (Labsynth) 
at 37°C/7d; and Malt Extract Agar (MEA, Difco) at 
25°C/7d (Klich, 2002).
Fig. 1. Location of the eight caves studied in the Iron Quadrangle (Minas 
Gerais State, Brazil): Rola Moça II Cave, Rola Moça III Cave, Macumba 
Cave, Romeiros Cave, Cascalhinho Cave, Eremita Cave, Bloco Abatido 
Cave, and Nossa Senhora da Conceição da Lapa Cave. State capital 
Belo Horizonte is also indicated.
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Thermotolerance assay
Before initiating the in vitro susceptibility assays, a 
preliminary triage was performed to exclude strains 
with negative growth at 37°C. The media used in this 
procedure were SDA (Difco) (25°C and 37°C for 7days) 
and Brain Heart Infusion Agar (BHIA, Acumedia) (37°C 
for 7 days). The strains presenting positive growth at 
37°C were submitted to in vitro drug susceptibility 
assays to amphotericin B (AMB), itraconazole (ITC), 
voriconazole (VCZ) and terbinafine (TBF). 
Minimum inhibitory concentration  
(MIC) determination
The minimum inhibitory concentration (MIC) for 
AMB (Sigma-Aldrich, St. Louis, Missouri, USA), 
ITC (Sigma-Aldrich), VCZ (Sigma-Aldrich) and TBF 
(Sigma-Aldrich) were determined by the antifungal 
microdilution susceptibility standard test proposed 
by the CLSI M38-A2 (CLSI, 2008). The inoculum 
was prepared in sterile saline solution and the 
transmittance of suspension was adjusted to 68-70% 
(530 nm) as standard protocol for filamentous fungi 
(M38 from CLSI). This suspension was diluted in RPMI-
1640 buffered with MOPS (Sigma-Aldrich) medium to 
achieve 1.0 x 103 to 5.0 x 103 CFU/mL (colony forming 
units per mL). The drugs were dissolved in 100% 
dimethylsulphoxide according to the protocol of CLSI 
at 1.0 mg/mL. Final concentrations ranged from 0.03 
to 16 µg/mL for AMB, ITC and VCZ and ranged from 
0.00195 to 1.0 µg/mL for TBF.
In each case, a volume of 100 µL of the inoculum 
suspension was transferred to sterile flat-bottom 96 
well plates containing100 µL of each of the antifungal. 
Control on RPMI-1640 was also performed (control 
growth). The plates were incubated at 37°C for 72h. 
All tests were performed in duplicate (for each strain).
Ergosterol quantification
Amphotericin B resistant (AmB-R) and amphotericin 
B susceptible (AmB-S) strains were cultured 
(37°C/72h) on SDA supplemented with AmB (1/2 MIC 
concentration) and approximately 10.0 mg of the 
fungal cell mass were transferred to polypropylene 
tubes. A growth control was also performed. For the 
extraction of lipids, 3 mL of ethanolic solution of 
potassium hydroxide 25% were added to each cell 
mass and agitated for one minute. The tubes were 
incubated in a water bath at 85°C for one hour and 
cooled at room temperature. A mixture of 1 mL of 
sterile water and 3 mL of n-heptane (Sigma-Aldrich) 
was added, followed by agitation in a vortex for three 
minutes. The supernatant was removed and the 
reading was performed in spectrophotometer at 282 
nm and 230 nm. A calibration curve with standard 
ergosterol (Sigma-Aldrich) was constructed and used 
to calculate the amount of ergosterol. The results were 
expressed as percentage of ergosterol in comparison 
with the growth control and represent the means of 
three independent experiments.
Lipid peroxidation assay 
Aspergillus strains were cultured (37°C/72h) on 
SDA supplemented with amphotericin B (1/2 MIC 
concentration) and hydrogen peroxide (HP) 1% 
as positive control. The products of the lipid 
peroxidation were measured as thiobarbituric acid-
reactive substances (TBARS). The pellet was frozen 
and homogenized with 1000 µL in ice-cold 1.1% 
phosphoric acid using water as diluent (v/v). Four 
hundred µL of the homogenate was mixed with 400 µL 
of 1% thiobarbituric acid (Sigma-Aldrich) prepared 
in 50 mM NaOH containing 0.1 mM butylated 
hydroxytoluene and 200 µL of 7% phosphoric acid (all 
the solutions were kept on ice during manipulation). 
Subsequently, samples (pH 1.5) were heated for 
60 minutes at 98°C and 1500 µL of butanol were added. 
The mixture was mixed vigorously using a vortex and 
centrifuged for five minutes at 2000 g. The organic layer 
was transferred and the absorbance was measured 
at 532 nm (Termo Scientific Multiscan spectrum, 
Termo Ficher Scientific). The thiobarbituric acid 
solution was replaced by 3 mM HCl in the controls. 
TBARS values were calculated using the extinction 
coefficient of 156 mM/cm and represent the means 
of three independent experiments. The results were 
expressed as the ratio between TBARS from cells 
treated with AMB or HP and the values registered in 
the control ± SE.
Enzymatic activity of the antioxidant system
Prior to the tests, a cell-free extract from susceptible 
and resistant strains of A. flavus were cultured 
(37°C/72 h) on SDA supplemented with AMB (1/2 MIC 
concentration) and on positive control with HP 1% 
according to the method described by Ferreira et al. 
(2013). Soluble protein was determined using the 
Bradford test using a standard curve of bovine serum 
albumin.
Peroxidase (PER) activity
The PER activity was analyzed according with 
method previously used (Ferreira et al., 2013) and 
measured in a system containing H2O2 and guaiacol 
as substrate. Values were obtained by monitoring 
the absorbance changes at λ = 470 nm using molar 
extinction coefficient value of 26.61 M-1cm-1 for the 
product tetra guaiacol formed by the enzymatic 
reaction. The data were calculated in nmols/min 
mg-1 of protein and represent the means of three 
independent experiments. The results were expressed 
as the ratio of nmols/min mg-1 of protein from cells 
treated with AMB or HP to the nmols/min mg-1 of 
protein from growth control ± SE.
Superoxide dismutase (SOD) activity
The SOD activity was measured by the inhibition 
of pyrogallol autoxidation as described previously 
(Ferreira et al., 2013). In the test samples, 100 µL 
of cell-free extract was added to pyrogallol and the 
inhibition of autoxidation was monitored every 30s for 
three minutes at a wavelength of 420 nm. The unit 
of SOD was considered as pyrogallol autoxidation per 
200 µL calculated as follows:
Unit of SOD mL-1 of sample = (A-B)/A x 50 x 100 x 0.6 
(dilution factor) where A is the difference in absorbance 
per minute in the control and B the difference in 
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absorbance per minute in the test samples. Data was 
calculated in units/mg of protein and represent the 
means of three independent experiments. The results 
were expressed as the ratio between the units/mg of 
protein extracted from cells treated with AMB or HP 
and the units/mg of protein from growth control ± SE. 
Statistical analysis
A Student’s two-tailed t test and a one-way analysis 
of variance (ANOVA) with the Bonferroni multiple-
comparison were used to compare the differences 
among groups. Significance was determined by values 
of p<0.05 in all experiments. The program used was 
Taxon
(strain no.)
Growth
(mm) Habitat
SDA BHI Substrate Zone of isolation Cave
25°C 37°C 37°C
Aspergillus candidus
UFMGLMCC03 17 8 3 Air Aphotic RM 3
UFMGLMCC028 20 12 11 Sediment Disphotic RM 3
UFMGLMCC011 20 5 3 Sediment Disphotic Gruta do Bloco Abatido
UFMGLMCC015 19 18 15 Sediment Aphotic Gruta do Cascalhinho
UFMGLMCC014 22 - - Air Disphotic RM3 
Aspergillus flavus
UFMGLMCC04 60 51 50 Air Disphotic Gruta do Eremita
UFMGLMCC05 62 50 50 Sediment Disphotic RM3
UFMGLMCC06 53 47 45 Sediment Disphotic Gruta da Macumba
UFMGLMCC09 62 44 49 Air Photic Gruta dos Romeiros
UFMGLMCC019 61 60 60 Air Disphotic Gruta N. S. Conceição
UFMGLMCC021 59 55 52 Sediment Aphotic Gruta N. S. Conceição
UFMGLMCC024 52 49 44 Sediment Disphotic Gruta do Cascalhinho
UFMGLMCC025 63 62 63 Sediment Disphotic Gruta RM2
UFMGLMCC026 70 66 65 Sediment Photic Gruta Eremita
UFMGLMCC027 58 55 59 Sediment Disphotic Gruta RM3
UFMGLMCC030 69 58 59 Sediment Aphotic Gruta N. S. Conceição
UFMGLMCC033 44 49 50 Vegetal debris Disphotic Gruta dos Romeiros
Aspergillus fumigatus
UFMGLMCC01 61 59 62 Air Aphotic RM 3
UFMGLMCC02 64 60 58 Sediment Disphotic Gruta N. S. Conceição
UFMGLMCC07 57 56 59 Sediment Aphotic Gruta do Bloco Abatido
UFMGLMCC013 68 62 59 Sediment Disphotic Gruta RM3
UFMGLMCC010 66 69 67 Sediment Disphotic Gruta do Cascalhinho
UFMGLMCC022 64 60 61 Sediment Disphotic Gruta N. S. Conceição
Aspergillus niger
UFMGLMCC016 70 68 68 Sediment Disphotic RM3
UFMGLMCC017 54 52 53 Sediment Disphotic Gruta RM2
UFMGLMCC018 71 64 61 Air Disphotic Gruta do Eremita
UFMGLMCC023 69 68 68 Air Disphotic Gruta do Eremita
UFMGLMCC029 57 49 52 Sediment Aphotic Gruta N. S. Conceição
UFMGLMCC034 62 60 62 Sediment Disphotic Gruta da Macumba
Aspergillus tamarii
UFMGLMCC012 49 36 39 Sediment Aphotic Gruta N. S. Conceição
UFMGLMCC020 53 53 51 Sediment Disphotic Gruta dos Romeiros
Aspergillus terreus
UFMGLMCC031 59 54 50 Sediment Disphotic Gruta do Bloco Abatido
UFMGLMCC032 62 59 55 Sediment Disphotic Gruta RM2
Table 1. Aspergillus strains isolated from caves in the Iron Quadrangle in Minas Gerais state, Brazil Growth rate of Aspergillus spp. on Sabouraud 
Dextrose Agar (25°C and 37°C) and Brain Heart Infusion (37°C) after seven days of incubation.
GraphPad Prism version 5.0 for Windows (GraphPad 
Software, San Diego, CA, USA).
RESULTS
A total of 33 strains of Aspergillus spp. were isolated 
in this study (Table 1). Thirty-two were able to grow at 
37°C. The results of growth and brief characterization 
of their habitat are shown in Table 1. 
In vitro susceptibility data
The MICs for azoles against the Aspergillus strains 
ranging between 2 µg/mL and >16 µg/mL to VCZ, and 
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between 0.25 and 8 µg/mL to ITC. Itraconazole had 
lower MIC values, with at least 50% of the Aspergillus 
strains inhibited at 0.5 µg/mL. The lower ITC MICs were 
observed against A. candidus and A. terreus (Table 2).
Amphotericin B had low MICs against the 
Aspergillus species tested, being the values below 
2 µg/mL for 29 strains. However the AMB MIC for 
three strains were 2 µg/mL (A. flavus, A. niger, and 
A. terreus) e.g., breakpoint determined by the CLSI; 
and 4 µg/mL for one strain of A. flavus. The mean 
value for AMB MIC50 was 0.5 µg/mL against A. 
candidus, A. flavus, A. fumigatus, A. tamarii, and A. 
terreus. For A. niger this value was lower with MIC 
of 0.25 µg/mL for at least fifty per cent of strains. 
The strain UFMGLMCC05 (A. flavus) was classified 
as amphotericin B-resistant (AmB-R) and submitted 
to further analysis of resistance mechanism. Finally, 
TBF MIC values ranged between 0.003 and 1 µg/mL 
(Table 2).
Amphotericin B-resistant versus  
susceptible A. flavus
AmB-R A. flavus (UFMGLMCC05) was collected from 
the sediment in the disphotic zone of RM3 cave where 
whitish/yellowish mats of actinomycetes (including 
Streptomyces spp., unpublished data) covered the 
sediment. The AmB-S used for comparison was 
obtained from our mycological collection and was 
firstly isolated from a highly visited show cave with 
no visible growth of actinomycetes (Aspergillus 
flavus UFMGLMCC103, Maquiné Cave/Cordisburgo, 
MG, Brazil). We have selected this AmB-S strain to 
eliminate possible local adaptive effects.
The AmB-R has higher levels of ergosterol than and 
AmB-S A. flavus in control media (p<0.05) and when 
exposed to AMB (p<0.05) (Fig. 2). Furthermore, the 
lipid peroxidation results (expresses as TBARS levels) 
showed that the AmB-R strain was less susceptible 
to oxidative stress caused by AMB and HP (p<0.05) 
(Fig. 3). The investigation of enzymatic activities of 
PER and SOD in response to oxidative stress showed 
that PER activity was similar between the AmB-S and 
AmB-R when treated with AMB. When treated with 
HP, AmB-S had lower PER activity compared with 
a large increase in AmB-R strain (Fig. 3) (p<0.05). 
On the other hand, the SOD activity was higher 
(p<0.05) in the AmB-R strain exposed to the drug and 
HP (Fig. 3).
DISCUSSION
Resistance to antibiotic compounds involve several 
mechanisms aimed at reducing drug content in the 
cell, decreasing interaction between the drug and 
its target, and metabolic modifications to counter 
balance the lethal effect of the drug (Vandeputte et 
al., 2012). It is evident that all mechanisms involved 
in drug-resistance result from an adaptive response 
and fitness enhancement (Anderson, 2005). This 
interaction is commonly triggered by contact with 
the drug due to soil/water contamination (clinical 
or agricultural use) or ecological interactions with 
organisms producing these antifungal agents in the 
Taxon
(strain no.) MIC (µg/mL )
AMB ITC VCZ TBF
Aspergillus candidus
UFMGLMCC03 1 0.5 8 0.0625
UFMGLMCC028 0.03 0.25 4 0.0625
UFMGLMCC11 0.5 0.5 4 0.125
UFMGLMCC15 0.5 0.5 4 0.003
MIC 50 (µg/mL )a 0.5 0.5 4 0.0625
Aspergillus flavus
UFMGLMCC04 0.5 4 4 0.125
UFMGLMCC05 4b 0.25 8 0.0625
UFMGLMCC06 0.5 4 >16b 0.0625
UFMGLMCC09 1 0.5 8 0.125
UFMGLMCC019 0.5 4 4 0.0312
UFMGLMCC021 0.5 0.5 8 0.0625
UFMGLMCC024 0.5 1 >16b 0.5
UFMGLMCC025 1 0.5 8 1b
UFMGLMCC026 1 0.5 8 0.0625
UFMGLMCC027 0.25 1 4 0.0625
UFMGLMCC030 2 4 4 0.001
UFMGLMCC033 1 8 16b 0.5
MIC 50 (µg/mL ) 0.5 1 8 0.0625
Aspergillus fumigatus
UFMGLMCC01 1 4 8 1
UFMGLMCC02 0.5 1 2 0.0625
UFMGLMCC07 1 4 4 0.125
UFMGLMCC013 0.5 0.5 4 0.0625
UFMGLMCC010 0.25 0.5 4 0.0625
UFMGLMCC022 0.5 4 8 0.003
MIC 50 (µg/mL ) 0.5 1 4 0.0625
Aspergillus niger
UFMGLMCC016 0.25 8 4 0.0625
UFMGLMCC017 0.25 8 4 0.001
UFMGLMCC018 0.25 8 8 0.0625
UFMGLMCC023 0.5 0.5 8 0.003
UFMGLMCC029 0.0125 0.25 8 0.0625
UFMGLMCC034 2 4 8 0.0625
MIC 50 (µg/mL ) 0.25 4 8 0.0625
Aspergillus tamarii
UFMGLMCC012 0.5 1 4 0.03
UFMGLMCC020 1 1 8 0.03
MIC 50 (µg/mL ) 0.5 1 4 0.03
Aspergillus terreus
UFMGLMCC031 2 0.5 4 0.25
UFMGLMCC032 1 0.25 4 0.125
MIC 50 (µg/mL ) 1 0.25 4 0.125
aMIC50: MIC value which inhibits 50% of the strains
environment (Anderson, 2005; Vandeputte et al., 2012). 
Although recent studies have focused in investigating 
drug resistance and mechanisms involved among 
cave isolated bacteria (Bhullar et al., 2012), this is the 
first study that aimed at investigating drug resistance 
among cave isolated filamentous fungi.
Table 2. Minimal Inhibitory Concentration (MIC) values (µg/mL) for 
amphotericin B (AMB), itraconazole (ITC), voriconazole (VCZ) and 
terbinafine (TBF) against thirty-two Aspergillus strains isolated from 
caves in Minas Gerais (Brazil).
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Fig. 2. Effect of amphotericin B (AMB) in susceptible and resistant 
Aspergillus flavus strains. Results are expressed in mg/mL. Data are 
represented as the mean + SEM of two independent experiments 
in triplicate assays. Statistically significant differences between the 
treatment and the control (no drug) are indicated with connect lines  
and between susceptible and resistant strains are indicated with 
asterisks (p<0.05). Amb-S = susceptible strain to amphotericin B; 
Amb-R = resistant strain to amphotericin B.
Fig. 3. Resistant cells are less susceptible to oxidative burst. (A) Lipid peroxidation (TBARs, thiobarbituric acid-reactive substances) (B) PER 
(peroxidase) (C) SOD (superoxide dismutase) activities after treatment with amphotericin B (AMB) and hydrogen peroxide (HP). Results are 
expressed as the ratio of the treatment to the control. Statistical differences are represented by the connect line (p < 0.05). Data represent the 
mean ± S.E. of two independent experiments consisting of triplicate assays. Amb-S = susceptible strain to amphotericin B; Amb-R = resistant 
strain to amphotericin B.
Terbinafine had the lowest MICs among the cave 
isolated fungi and the lower MICs with no resistant 
strains. Although TBF is not usually used in treatment 
of invasive pulmonary aspergillosis (Kousha et al., 
1999), its use combined with AMB and azoles has 
been investigated (Ryder & Leitner, 2001; Mosquera 
et al., 2002; Cuenca-Estrella, 2004; Fernandez et 
al., 2015). Additive and synergistic relations have 
been reported between triazoles and TBF, as well as 
sinergism between AMB and TBF (Singh & Paterson, 
2005). Additionally the AmB-resistant A. flavus had 
low TBF MICs, which is a result that deserves further 
evaluation aimed at combined use of drugs. 
Our results clearly showed that, among the azoles, 
ITC had lower MIC values against the strains tested 
when compared with VCZ. Döring and colleagues 
(2014) reported similar result with ITC in clinical 
strains obtained from paediatric patients. Indeed, 
it is important to highlight that our samples came 
from iron-rich sediment, which could be inducing 
resistance mechanisms against azoles as already 
observed in clinical and in vivo assays (Prasad et al., 
2006; Craven et al., 2007; Zarember et al., 2009; 
Chowdhary et al., 2013; Hosogaya et al., 2013).
Hosogaya and colleagues (2013) showed a strong 
positive relation between iron concentrations and 
resistance to azoles in Candida glabrata. The authors 
showed that the protein Dap1 is indirectly involved 
in the ergosterol biosynthesis and their results 
suggested heme binding by Dap1 is crucial for Erg11 
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activity and ergosterol biosynthesis, thereby being 
required for azole tolerance. Similar relation between 
iron depletion and susceptibility to azoles in yeasts 
(Prasad et al., 2006; Craven et al., 2007) and the 
filamentous fungi A. fumigatus (Zarember et al., 2009) 
has been reported. Our results open to a discussion 
on the role of iron concentrations in natural habitats 
and resistance to azoles that certainly deserves special 
attention in future investigations. 
Despite its high toxicity, AMB is still used against 
IPA (Kousha et al., 1999). Amphotericin B MICs 
commonly range between 0.25 and 2 µg/mL (Kazemi et 
al., 2013) with resistance breakpoint at MIC >2 µg/mL 
(CLSI, 2008). Although results with AMB were lower 
in our study (with MIC50 at 0.5 µg/mL), a resistant 
strain of A. flavus was detected and other strains 
had MICs at breakpoint value (A. flavus and A. terreus). 
The high MICs observed in A. terreus to AMB, was 
not surprising, since resistance to AMB has already 
been reported for this species (Sutton et al., 1999; 
Singh & Paterson, 2005). To our knowledge this is 
the first report of an AmB-resistant strain of A. flavus 
isolated directly from cave sediment. Resistance 
to AMB has already been documented for other 
Aspergillus species obtained from clinical samples 
(Blum et al., 2008; Van Der Linden et al., 2011; 
Hadrich et al., 2012).
Interestingly, the resistant strain was collected 
from the sediment of an aphotic site covered with 
numerous actinomycete colonies. As mentioned by 
Khoo et al. (1994), AMB was firstly obtained from 
filamentous bacteria (Streptomyces nodosus). It has 
been recently reported that other microorganisms 
inhabiting extreme environments also produce AMB 
as survival mechanism enhancing their ecological 
fitness in competing for substrate (Svahn et al., 2015). 
Additionally, Seo et al. (1999) induced resistance 
to AMB from a wild strain of A. flavus after several 
conidial transfers on AMB enriched media. This 
could be occurring naturally among wild strains in 
the environment. It is plausible to hypothesize that 
constant natural exposure to antifungal compounds 
produced by competitors (bacteria or fungi) induces 
natural selection of drug-resistant strains. Similar 
relation has been reported among cave isolated 
bacteria (Bhullar et al., 2012). The authors detected 
resistance to over fourteen antibiotics by bacteria 
isolated from a pristine cave in the United States 
and associated resistance with their pan genome and 
adaptive response to ecological interactions.
Concerning the investigation of resistance 
mechanisms, it has been widely considered that the 
main antifungal action of AMB derives from the binding 
between ergosterol and AMB altering membrane 
permeability and causing leackage of cytoplasmatic 
components (Ermishkin et al., 1976; Khoo et al., 
1994; Johnson & Einstein 2007; Laniado-Laborín & 
Cabrales-Vargas, 2009). Thus, some authors have 
associated the main resistance mechanism to AMB 
with decrease of ergosterol content to diminish binding 
sites. Others pointed that ergosterol decrease is not 
the main resistance mechanism in Aspergillus spp. 
(Alcazar-Fuoli et al., 2006; Blum et al., 2008; Alcazar-
Fuoli & Mellado, 2013) with resistance being more 
related with response to oxidative stress (Blum et al., 
2013). Our results showed a substantial ergosterol 
increase in the AmB-R strain when exposed to the 
agent. It is important to highlight that ergosterol 
is involved in several relevant functions in fungi 
(e.g., hyphal growth, conidiation, protection) and its 
decrease has been classified as a secondary resistance 
mechanism (Laniado-Laborín & Cabrales-Vargas, 
2009; Mesa-Arango et al., 2014). Furthermore, the 
resistant strain showed lower susceptibility to free 
radicals, probably due to the overexpression of the 
antioxidant system. Our group previously showed that 
AMB led to ROS formation and lipid peroxidation in 
yeast cells (Cryptococcus gattii) and this phenomenon 
strongly increased the enzymatic activities of the 
antioxidant system (Ferreira et al., 2013).
The data obtained in the enzymatic assay (PER 
and SOD) showed that SOD played major role in 
the resistance of A. flavus isolated from RM3 cave. 
Fungal AMB-resistance has been related with 
enzymatic activity against oxidative stress for 
some fungi (Laniado-Laborín & Cabrales-Vargas, 
2009; Mesa-Arango et al., 2014). Blum et al. (2008) 
showed that AMB-resistance in A. terreus was highly 
related with catalase production. Okamoto et al. 
(2004) showed that oxidative damage induced by 
superoxide was the main activity of AMB against 
the yeast C. albicans. In the other hand, it seems 
that peroxidases did not play a crucial role in the 
resistance mechanism against AMB. 
Caving is a common practice that has been 
increasing worldwide, causing various impacts on the 
subterranean biodiversity (Cigna, 1993; Souza-Silva, 
2008; Lobo & Moretti, 2009; Souza-Silva & Ferreira, 
2009; Kartalis et al., 2011; Taylor et al., 2013). The 
use of ground water and pieces of speleothems for 
curative purposes by local population should also 
be mentioned (Souza-Silva et al., 2011; Taylor et 
al., 2013) especially considering the impacts and 
risks posed by this activity. The transport of cave 
microorganisms and their contact with individuals of 
poor immunologic conditions enhance the chances 
of infection by drug-resistant strains. Despite being 
important components of cave biodiversity microbial 
communities have been poorly investigated in 
management plans and monitoring of subterranean 
ecosystems (Bhullar et al., 2012; Taylor et al., 
2013; Vanderwolf et al., 2013). In the past decade, 
Brazilian governmental agencies have required more 
detailed microbiological inventories in caves to reduce 
chances of fungal outbreaks. Although the chances 
of developing pulmonary fungal infections by other 
species than Histoplasma capsulatum while caving are 
scarce, these opportunistic infections are emerging 
diseases and should be more thoroughly investigated, 
as well as their resistance mechanisms. The high 
resistance to AMB observed corroborates with the idea 
that antibiotic resistance might be a natural event, 
resulting from competition among soil organisms and 
their metabolites.
In conclusion, our findings broaden the knowledge 
concerning the action of AMB against A. flavus and the 
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mechanisms of resistance involved. We also speculate 
that interactions with environmental conditions (e.g., 
iron concentration) and between organisms lead to an 
adaptive response towards natural selection of drug 
resistant microorganisms in caves.
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